Return to search

Developmental variation in the rate of Collagen deposition in the cardiac basement membrane

Cardiovascular disease is a leading cause of morbidity worldwide. Many cardiomyopathies and developmental defects arise from misregulation of the cardiac extracellular matrix (ECM), a dynamic network of proteins, growth factors, and signaling molecules that form a protective sheath around organs and tissues. Changes in ECM composition are mediated in part by matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs (TIMPs). ECM dysregulation leads to outcomes such as fibrotic scarring, hypertrophy, and myocardial infarction. Although fundamental to heart formation and function, the regulation of ECM integration and remodeling during growth is poorly understood. To investigate this, I developed a novel adaptation of fluorescence recovery after photobleaching (FRAP), which, for the first time, allows us to assess ECM protein incorporation during growth in live, intact Drosophila larvae. As such, recovery of fluorescently tagged proteins is a proxy for addition or relocation of ECM protein. We focus on Collagen IV (Viking), a conserved protein and major constituent of the basement membrane (BM). Integration and stabilization of Collagen IV in the BM is poorly understood, however is known to be mediated in part by Collagen modifying proteins secreted protein acidic and rich in cysteine (SPARC) and lysyl oxidase (Lox) are known. We established a time course for Vkg-GFP fluorescence accretion in the heart and body wall muscle throughout larval development, under normal conditions and those in which mmp2 or timp is overexpressed. We also observed the effects reducing the activity of SPARC and Lox Vkg dynamics in the early third instar cardiac ECM. In wildtype, we report a strong phasic pattern of Vkg accumulation at second to third instar ecdysis, potentially to support growth of the succeeding instar. Heart-specific overexpression of mmp2 and timp, the inhibitor of mmp2, perturbs net fluorescence recovery as well as estimated turnover of Vkg-GFP. Our results suggests that MMPs are positive regulators of Vkg/Col IV turnover in the ECM, which is in alignment with other recent studies (Davis et al., 2022; Töpfer et al., 2022). Loss of SPARC and Lox appears to affect estimated Vkg turnover in the cardiac ECM, consistent with a role for these proteins in integrating and stabilizing Collagen IV in the BM. These findings have implications in cardiac conditions and in other ECM-related disorders and diseases such as connective tissue disorders, muscular dystrophy, fibrosis, and cancer. / Thesis / Doctor of Science (PhD)

Identiferoai:union.ndltd.org:mcmaster.ca/oai:macsphere.mcmaster.ca:11375/28997
Date January 2023
CreatorsMacDuff, Danielle
ContributorsJacobs, Roger, Biology
Source SetsMcMaster University
LanguageEnglish
Detected LanguageEnglish
TypeThesis

Page generated in 0.0014 seconds